Omicron-specific Sinopharm, Sinovac COVID vaccine candidates

Advertise with us

Advertise with us

QatarDay

Health & Wellbeing

Sinopharm

Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday. Scientists worldwide are racing to ..
Sinopharm protein-based booster stronger against Omicron than earlier shot -study

A protein-based COVID-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a stronger antibody response against the Omicron variant than a third dose of the original, a study showed...
Peru study finds Sinopharm COVID vaccine 50.4% effective against infections

REUTERS A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants, and booster shots can be considered, a study found..
Saudi Arabia allows entry of Sinopharm and Sinovac vaccinated people after Booster dose

Saudi Arabia has decided to allow entry to foreign travellers fully vaccinated with either Sinopharm or Sinovac vaccines, provided that they also receive a booster shot of either of the four vaccines approved by the Kingdom, according to the country&..

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories